Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Daniel Mark Bradbury is an American entrepreneur and businessperson who founded Equillium, Inc., BioBrit LLC and Sensulin LLC and who has been at the head of 9 different companies. Currently, Mr. Bradbury is Chairman at Castle Biosciences, Inc., Chairman at Liquidgrids, Inc., Chairman at Thesan Pharmaceuticals, Inc., Chairman of Freedom Meditech, Inc., Chairman at Sensulin LLC, Chairman of ADCY5 Org and Executive Chairman at Equillium, Inc. Daniel Mark Bradbury is also Member of Royal Pharmaceutical Society of Great Britain and Managing Member at BioBrit LLC and on the board of 18 other companies.

Mr. Bradbury previously occupied the position of Chairman at NeuroVia, Inc., President, Chief Executive Officer & Director at Amylin Pharmaceuticals, Inc. and Principal at Smithkline Beecham Pharmaceuticals (India) Ltd.

Daniel Mark Bradbury received an undergraduate degree from The University of Nottingham.


Current positions of Daniel Mark Bradbury 
NameTitle Since
Biocon Limited
(Biotechnology & Medical Research)
Independent Non-Executive Director 2013
Castle Biosciences, Inc.
(Medical Equipment, Supplies & Distribution)
Chairman 2014
Intercept Pharmaceuticals, Inc.
(Biotechnology & Medical Research)
Independent Director 2016
Equillium, Inc.
(Pharmaceuticals)
Executive Chairman 2020
Liquidgrids, Inc. Chairman 2014
Thesan Pharmaceuticals, Inc. Chairman 2016
Sensulin LLC Chairman 2014
ADCY5 Org Chairman -
BioMed Realty LP Director -
AltheaDx, Inc. Director 2020
Synedgen, Inc. Director -
Microdermis Corp. Director -
DiaVacs, Inc. Director -
BIOCOM Director -
Keck Graduate Institute of Applied Life Sciences Trustee 2006
Profil Institute for Clinical Research, Inc. Director 2013
The Riecken Foundation Director -
Freedom Meditech, Inc. Chairman 2014
Renova Therapeutics, Inc. Director 2014
Biocon Research Ltd. Director -
Biolinq, Inc. Director -
DelNova, Inc. Director -
Biocon Biologics Ltd. Director 2019
ProSciento, Inc. Director -
Biocon Biologics Uk Ltd. Director 2019
Royal Pharmaceutical Society of Great Britain Member -
BioBrit LLC Managing Member 2012


Holdings of Daniel Mark Bradbury 
NameEquities%Valuation
Equillium, Inc. (EQ)
(Pharmaceuticals)
742,3992.53%4,565,754 USD
Intercept Pharmaceuticals, Inc. (ICPT)
(Biotechnology & Medical Research)
15,8110.048%235,742 USD
Nuvation Bio Inc. (NUVB)
(Biotechnology & Medical Research)
25,0000.011%230,750 USD


Daniel Mark Bradbury: Personal Network 
Most Read News 
09/22WILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/24CATHIE WOOD : Chinese crackdown on bitcoin another blow to Cathie Wood's ARK ETF
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/22CATHIE WOOD : ARK's Cathie Wood says Wall Street not in a bubble
RE
09/24ELON MUSK : New semiconductor plants will end global auto chip shortage next year -Tesla's Musk
RE
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/24BARRY DILLER : Stock Futures Weaken After Evergrande Payment Deadline Passes
DJ
More news


© 2021 People and Ownership :   
Daniel Mark Bradbury : Connections